Presentation and Status in Health Basket
1 Vial x 25 U/0.5 ml
1 Vial x 50 U/ml
Active pre-exposure prophylaxis against disease caused by Hepatitis A virus in persons 2 years and older. Primary immunization should be given at least 2 weeks prior to expected exposure to HIV.
See prescribing information for full details.
Hypersensitivity to any component of the vaccine.
Will not prevent hepatitis caused by infectious agents other than hepatitis A virus, bleeding disorders in people who are at risk of hemorrhage, acute infection or febrile illness, pregnancy and lactation.
No serious vaccine-related adverse experiences were observed during clinical trials.